Illumina Ventures’ Diagnostics Year in Review 2024 Report
Latest industry segment report offering key insights into the current trends, challenges and opportunities facing the diagnostics industry.
News
listing-news
Latest News
Attovia Therapeutics Announces $90 Million Series C Financing to Advance ATTOBODY-based Programs through Clinical Proof of Concept
Series C round led by Deep Track Capital with participation from additional new and existing investors; financing will fund early-to-mid-stage clinical studies for ATTO-1310 in chronic pruritus and ATTO-3712 in atopic dermatitis, and multiple earlier-stage multi-specific programs.
Spotlight on Remi Dangla, PhD – CEO Stilla Technologies April 2025
Spotlight on Remi Dangla, PhD – CEO Stilla Technologies
Spotlight on Yuling Luo, PhD – CEO Alamar Biosciences January 2025
Spotlight on Yuling Luo, PhD – CEO Alamar Biosciences
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
0 selected
Generating previews...